SPRINT results in older patients how low to go?

JAMA - Journal of the American Medical Association

Volumn 315, Issue 24, 2016, Pages 2669-2670

  Chobanian, Aram V ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

AGING; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL STUDY; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; ACUTE CORONARY SYNDROME; FEMALE; HEART FAILURE; HEART INFARCTION; MALE;

ACUTE CORONARY SYNDROME; ANTIHYPERTENSIVE AGENTS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MYOCARDIAL INFARCTION;

EID: 84976351019     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.7070     Document Type: Editorial

References (11)

1. Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged 75 years: A randomized clinical trial. JAMA. doi:10.1001/jama.2016.7050.
2. Wright JT Jr, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive vs standard blood pressure control. N Engl J Med. 2015;373(22):2103-2116.
3. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002;287(8):1003-1010.
4. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289(19): 2560-2572.
5. Lewington S, Clarke R, QizilbashN, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: Ameta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903-1913.
6. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255- 3264.
7. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358 (18):1887-1898.
8. James PA, Oparil S, Carter BL, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
9. Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR. Evidence supporting a systolic blood pressure goal of less than 150mmHg in patients aged 60 years or older: The minority view. Ann Intern Med. 2014;160(7):499-503.
10. Cushman WC, Evans GW, Byington RP, et al; ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575-1585.
11. Chobanian AV. Shattuck Lecture: The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med. 2009; 361(9):878-887.